Mgi Tech's Gene Sequencing Instrument Secures Medical Device Registration Certificate

Stock News04-10 17:36

Mgi Tech Co., Ltd. (688114.SH) announced that its wholly-owned subsidiary, Shenzhen Mgi Tech Bioelectronics Co., Ltd., has recently obtained a Medical Device Registration Certificate from the People's Republic of China for its gene sequencing instrument. The product utilizes Combinatorial Probe-Anchor Synthesis sequencing technology and is clinically intended for sequencing DNA and RNA derived from human samples to detect gene sequences. These sequences can be used to assist in the diagnosis of diseases or disease susceptibility. The instrument is clinically limited to use in conjunction with in vitro diagnostic reagents and software approved by the National Medical Products Administration and is not intended for whole human genome sequencing or de novo sequencing.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment